Phillip Frost Files Form 4 — Major OPK Share Dispositions and Indirect Holdings
Rhea-AI Filing Summary
Phillip Frost M.D. and related entities reported multiple dispositions of OPKO HEALTH, INC. (OPK) common stock on 08/18/2025. The Form 4 shows a reported sale (transaction code G) of 440,000 shares for $0 and additional dispositions of 3,568,951 shares. Following the reported transactions, the filing lists 214,236,448 shares and 30,127,177 shares held indirectly by affiliated trusts and entities, with ownership described in footnotes clarifying trustee/beneficiary relationships. The filing is signed by Phillip Frost, M.D., individually and as trustee, indicating the report covers both his individual and related trust holdings.
Positive
- Timely disclosure of insider transactions via a filed Form 4, satisfying Section 16 reporting requirements
- Detailed ownership footnotes clarify trustee, beneficiary and partnership relationships for indirect holdings
Negative
- Large dispositions reported: 440,000 shares and 3,568,951 shares disposed on 08/18/2025
- Substantial indirect holdings remain with affiliated entities: 214,236,448 shares and 30,127,177 shares, indicating material insider exposure
Insights
TL;DR Insider reported large dispositions and substantial indirect holdings through affiliated trusts; filing documents governance relationships.
The Form 4 discloses significant share movements by Phillip Frost and affiliated entities on 08/18/2025. The largest reported numeric items are disposals of 440,000 and 3,568,951 shares and indirect holdings of 214,236,448 and 30,127,177 shares across Frost-controlled trusts and partnerships. Footnotes detail trustee/beneficiary and limited partner structures, and the reporting person disclaims beneficial ownership except for pecuniary interest. The disclosure is procedural and clarifies ownership chains relevant for Section 16 compliance.
TL;DR Filing documents material insider dispositions and explains complex indirect ownership via trusts and partnerships.
The report emphasizes legal ownership structure: Frost Gamma Investments Trust and Frost-Nevada entities are identified as holders, with Dr. Frost as trustee or controlling shareholder in related entities. The filing includes explicit disclaimers of beneficial ownership except for pecuniary interest, and it is signed by Dr. Frost as required. These details are important for accurately attributing voting and economic interests under disclosure rules.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 440,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
